<code id='7EBDC64833'></code><style id='7EBDC64833'></style>
    • <acronym id='7EBDC64833'></acronym>
      <center id='7EBDC64833'><center id='7EBDC64833'><tfoot id='7EBDC64833'></tfoot></center><abbr id='7EBDC64833'><dir id='7EBDC64833'><tfoot id='7EBDC64833'></tfoot><noframes id='7EBDC64833'>

    • <optgroup id='7EBDC64833'><strike id='7EBDC64833'><sup id='7EBDC64833'></sup></strike><code id='7EBDC64833'></code></optgroup>
        1. <b id='7EBDC64833'><label id='7EBDC64833'><select id='7EBDC64833'><dt id='7EBDC64833'><span id='7EBDC64833'></span></dt></select></label></b><u id='7EBDC64833'></u>
          <i id='7EBDC64833'><strike id='7EBDC64833'><tt id='7EBDC64833'><pre id='7EBDC64833'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:258
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’
          Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

          PaulTonkoofNewYork:“Thispackagefallsfarshortoftakingthenecessarystepstoaddressthedeepneedofthiscrisi

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          EU fines Illumina $475 million over Grail acquisition

          AdobeLONDON—TheEuropeanUniononWednesdayissuedanantitrustfineof$475milliontotheU.S.geneticsequencingg